Reaction

Streptococcal Bacteraemia reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,061 reports · 69 co-occurring drugs

As of the last recalculation, Streptococcal Bacteraemia appears in 1,061 FAERS reports alongside 69 co-occurring drug terms. The strongest observed disproportionality signal is SIROLIMUS (PRR 41.8).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Sirolimus	28	41.8	41.9
Thiotepa	19	39.7	39.8
Cytarabine	99	35.5	35.6
Fludarabine Phosphate	62	32.8	32.8
Prochlorperazine	43	31.7	31.7
Vincristine Sulfate	45	31.4	31.5
Dalteparin Sodium	16	30.1	30.2
Polyethylene Glycol	16	29.4	29.5
Busulfan	23	29.3	29.3
Ganciclovir	14	27.2	27.2
Ganciclovir Sodium	14	26.3	26.3
Filgrastim	48	26.2	26.2
Pegaspargase	15	24.4	24.4
Etoposide	75	21.5	21.5
Melphalan	24	21.2	21.2
Bleomycin Sulfate	11	21.1	21.1
Melphalan Hydrochloride	26	20.8	20.8
Valacyclovir	41	20.0	20.0
Azacitidine For	18	19.7	19.7
Valganciclovir Hydrochloride Powder,	12	19.5	19.5
Amphotericin B	12	19.0	19.0
Micafungin Sodium	8	18.6	18.7
Piperacillin And Tazobactam	12	18.6	18.6
Posaconazole	15	18.4	18.4
Piperacillin Sodium,Tazobactam Sodium	24	18.1	18.2
Anti-Thymocyte Globulin (Rabbit)	7	17.1	17.1
Itraconazole	10	16.9	17.0
Mesna Injection	7	16.7	16.7
Mesna	7	16.4	16.4
Cholestyramine	10	16.4	16.4
Posaconazole Delayed-Release	9	16.2	16.2
Aprepitant	15	16.2	16.2
Fosaprepitant Dimeglumine	11	15.8	15.9
Valganciclovir	15	15.8	15.8
Valganciclovir Hydrochloride	15	15.8	15.8
Azacitidine	23	15.5	15.5
Cyclophosphamide Injection, Solution	123	15.3	15.3
Cyclophosphamide	123	15.3	15.3
Cyclophosphamide For Injection	123	15.3	15.3
Ifosfamide	16	14.8	14.8
Vancomycin	42	14.8	14.8
Valacyclovir Hydrochloride	49	14.3	14.3
Piperacillin Sodium And Tazobactam Sodium	14	14.2	14.2
Doxorubicin Hydrochloride	23	14.1	14.1
Tacrolimus Ointment 0.1%	82	13.9	13.9
Tacrolimus Extended-Release Capsules	82	13.9	13.9
Vancomycin Hydrochloride	44	13.6	13.6
Cefepime Hydrochloride	11	13.5	13.5
Alteplase	10	13.2	13.2
Heparin Sodium	9	12.9	12.9
Cefepime	9	12.4	12.4
Doxorubicin	51	11.7	11.8
Levodopa	7	11.4	11.4
Dasatinib	19	10.2	10.2
Fluorouracil Cream, 0.5%	37	9.8	9.8
Venetoclax	30	9.8	9.8
Fluorouracil	37	9.7	9.7
Cisplatin	37	9.6	9.6
Blinatumomab	5	9.4	9.4
Irinotecan Hydrochloride	6	9.2	9.2
Voclosporin	4	9.1	9.1
Sevelamer Carbonate	5	8.6	8.6
Bendamustine Hydrochloride	5	8.2	8.2
Docetaxel Anhydrous	24	7.1	7.1
Docetaxel	24	7.1	7.1
Carfilzomib	10	7.0	7.0
Daratumumab	13	6.5	6.5
Ixazomib	9	6.2	6.2
Axicabtagene Ciloleucel	3	6.0	6.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.